science

Post-exposure prophylaxis

Post-exposure prophylaxis is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Post-exposure prophylaxis rather than just read about it. In short: Post-exposure prophylaxis, also known as post-exposure prevention (PEP), is any preventive medical treatment started after exposure to a pathogen in order to prevent the infection from occurring. It should be contrasted with pre-exposure prophylaxis, which is used before the patient has been exposed to the infective agent.

Key takeaways

Post-exposure prophylaxis belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Post-exposure prophylaxis to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Post-exposure prophylaxis from memory before moving on to harder problems.

Reference excerpt

Post-exposure prophylaxis, also known as post-exposure prevention (PEP), is any preventive medical treatment started after exposure to a pathogen in order to prevent the infection from occurring. It should be contrasted with pre-exposure prophylaxis, which is used before the patient has been exposed to the infective agent.

COVID-19 In 2021, the US FDA gave emergency use authorization (EUA) to bamlanivimab/etesevimab for post-exposure prophylaxis against COVID-19. However, due to its reduced effectiveness against Omicron variants of the SARS-CoV-2 virus, it is no longer recommended for this purpose. Ensitrelvir has been studied for its potential use as post-exposure prophylaxis against COVID-19 in a phase 3 clinical trial. In 2025, the SCORPIO-PEP trial found the treatment with ensitrelvir significantly reduced the incidence of symptomatic COVID-19 in people who had a household exposure to the illness compared to a placebo. In clinical observations, only 2.9% of the ensitrelvir group developed symptoms, versus 9.0% in the control group, representing a 67% reduction in risk. In September 2025, the FDA accepted a New Drug Application from the manufacturer for ensitrelvir as PEP for COVID-19, and was approved for this use on 29 May 2026.

Rabies PEP is commonly and very effectively used to prevent the onset of rabies after a bite by a suspected-rabid animal, since diagnostic tools are not available to detect rabies infection prior to the onset of the nearly always-fatal disease. The treatment consists of a series of injections of rabies vaccine and immunoglobulin. Rabies vaccine is given to both humans and animals who have been potentially exposed to rabies. As of 2018, the average estimated cost of rabies post-exposure prophylaxis was US$108 (along with travel costs and loss of income).

Tetanus Tetanus toxoid can be given in case of a suspected exposure to tetanus. In such cases, it can be given with or without tetanus immunoglobulin (also called tetanus antibodies or tetanus antitoxin). It can be given as intravenous therapy or by intramuscular injection. The guidelines for such events in the United States for non-pregnant people 11 years and older are as follows:

HIV

History AZT was approved as a treatment for AIDS in 1987. Healthcare workers would occasionally be exposed to HIV during work. Some people thought to try giving health care workers AZT to prevent seroconversion. This practice dramatically decreased the incidence of seroconversion among health workers when done under certain conditions. Later the questions arose of whether to give HIV treatment after known exposure or high risk of exposure. Early data from preclinical studies established the efficacy of AZT in preventing transmission of HIV infection. AZT was also seen to reduce maternal-infant transmission of HIV in a randomized controlled trial, suggesting AZT's post-exposure prophylaxis (PEP) use. Subsequent data show combination antiretroviral therapy is significantly superior than AZT in reducing perinatal transmission rates. In addition, AZT is generally no longer recommended due to poor tolerance resulting in high rates of patient noncompliance. Non-occupational exposures include cases when a condom breaks while a person with HIV has sex with an HIV-negative person in a single incidence, or in the case of unprotected sex with an anonymous partner, or in the case of a non-habitual incident of sharing a syringe for injection drug use. Evidence suggests that PEP also reduces the risk of HIV infection in these cases. In 2005, the US DHHS released the first recommendations for non-occupational PEP (nPEP) use to lower risk of HIV infection after exposures. The recommendations were replaced with an updated guideline in 2016. Occupational exposures include needlestick injury of health care professionals from an HIV-infected source. In 2012, the US DHHS included guidelines on occupational PEP (oPEP) use for individuals with HIV exposures occurring in health care settings. Since taking HIV-attacking medications shortly after exposure was proven to reduce the risk of contracting HIV, this led to research into pre-exposure prophylaxis by taking medication before a potential exposure to HIV occurred. A report from early 2013 revealed that a female baby born with the HIV virus displayed no sign of the virus two years after high doses of three antiretroviral drugs were administered within 30 hours of her birth. The findings of the case were presented at the 2013 Conference on Retroviruses and Opportunistic Infections in Atlanta, U.S. and the baby is from Mississippi, U.S. The baby—known as the "Mississippi baby"—was considered to be the first child to be "functionally cured" of HIV. However, HIV re-emerged in the child as of July 2014.

… excerpt ends here. Continue reading the full article.

Worked examples

Example 1 — a first encounter with Post-exposure prophylaxis

Start with the simplest possible case. Write down what Post-exposure prophylaxis claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Post-exposure prophylaxis before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Post-exposure prophylaxis ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Post-exposure prophylaxis

In research: Post-exposure prophylaxis appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Post-exposure prophylaxis in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Post-exposure prophylaxis is common in secondary-school and first-year university syllabi. It links to neighbouring topics Medical treatments, Prevention of HIV/AIDS, so understanding it makes those chapters shorter.
In everyday life: Look for Post-exposure prophylaxis outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Post-exposure prophylaxis” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Post-exposure prophylaxis in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Post-exposure prophylaxis means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Post-exposure prophylaxis out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Post-exposure prophylaxis in simple terms?

Why does Post-exposure prophylaxis matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Post-exposure prophylaxis?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Post-exposure prophylaxis.